Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high‐risk groups in neuroblastoma

16 May 2003

Abstract excerpt

BACKGROUND: The prognostic chromosomal markers 1p loss and MYCN amplification (MNA) are only present in a subgroup of approximately 30% of neuroblastomas. To further characterize high and low risk subsets we investigated alterations in chromosome arms 3p and 11q, additional changes in 1p and MYCN as well as the somy-status of chromosome 1 in the same sample. PROCEDURE: Fluorescence in situ hybridization (FISH)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microtubule and mitosis dynamics
Share to Neuroblastoma Research and Treatments
Share to Nuclear Structure and Function

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12764740
DOI: 10.1002/mpo.10313

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high‐risk groups in neuroblastomaPMID 12764740Read ↗

Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosisSemantic proximity Read ↗

Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaSemantic proximity Read ↗

Loss in Chromosome 11q Identifies Tumors with Increased Risk for Metastatic Relapses in Localized and 4S NeuroblastomaSemantic proximity Read ↗

Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaSemantic proximity Read ↗

Oligonucleotide array‐based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcomeSemantic proximity Read ↗

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.Semantic proximity Read ↗

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.Semantic proximity Read ↗

Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.Semantic proximity Read ↗

Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.Semantic proximity Read ↗

MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastomaSemantic proximity Read ↗

Neuroblastoma: Effect of genetic factors on prognosis and treatmentSemantic proximity Read ↗

The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.